]

Gaining Ground

TB Alliance Annual Report 2020
CEO LETTER

A Message from the CEO and Board Chair

We’ve made progress in developing new treatments under uniquely challenging conditions to help improve the lives of those impacted by TB around the world.

Read more
R&D

Researching New Cures

Results from late-stage clinical trial research demonstrates potential for new treatments.

Learn more
ACCESS

Reaching Patients

TB Alliance and partners are working to accelerate global approvals and accessibility of new treatments in the fight against TB.

Read more
Discovery

The Future of TB Treatment

Finding short, effective and simple regimens is our goal and our scientists are exploring ways to improve the treatment experience for patients.

Learn more
Partners

The Promise of Partnerships

Over the past 20 years, we’ve advanced toward our goal to end TB and, with help from partners and the global TB community, we continue to strive to make this vision a reality.

Read more

TB Alliance in 2020

An overview of the milestones TB Alliance achieved toward our goal to develop new, better treatments for all forms of TB.

Cover photo shows historic drug-resistant TB treatment (right) and the BPaL regimen (left).

Annual Report 2020